Cargando…
1522. Penicillin plus ceftaroline against Enterococcus faecalis blood isolates lacking ampicillin plus ceftriaxone activity
BACKGROUND: Enterococcus faecalis infective endocarditis standard of care treatment, ampicillin plus ceftriaxone, unfortunately has been unable to decrease mortality rates and additionally increases patient risk for vancomycin-resistant enterococci (VRE). Recent data also demonstrates decreased ampi...
Autores principales: | Nwoye, Angella, Bocanegra, Jessica, Khan, Ruhma, Shah, Zeel, Cusumano, Jaclyn A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752263/ http://dx.doi.org/10.1093/ofid/ofac492.084 |
Ejemplares similares
-
Penicillin plus Ceftriaxone versus Ampicillin plus Ceftriaxone Synergistic Potential against Clinical Enterococcus faecalis Blood Isolates
por: Cusumano, Jaclyn A., et al.
Publicado: (2022) -
681. Penicillin Plus Ceftriaxone Against Enterococcus faecalis In Vitro Time-Kill Studies
por: Khan, Ruhmazia, et al.
Publicado: (2021) -
1559. Ertapenem Plus Ceftriaxone or Ceftaroline Dual Β-Lactam Combination for Enterococcus faecalis
por: Cusumano, Jaclyn A, et al.
Publicado: (2019) -
184. Implications of Enterococcus faecalis penicillin susceptibility in patients with bacteremia
por: Hedvat, Jason, et al.
Publicado: (2023) -
Ampicillin Plus Ceftriaxone Combined Therapy for Enterococcus faecalis Infective Endocarditis in OPAT
por: Herrera-Hidalgo, Laura, et al.
Publicado: (2021)